Author

K. Giannikou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

A. K. Perl· 1 shared A. Moran-Horowich· 1 shared A. Potter· 1 shared C. Probst· 1 shared D. J. Kwiatkowski· 1 shared D. Kwiatkowski· 1 shared D. O. Lopez-Cantu· 1 shared D. R. Lemos· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Perl

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Tissue-Bioengineering Strategy for Modeling Rare Human Kidney Diseases In Vivo

J. Hernandez, X. Wang, M. Vazquez-Segoviano, M. F. Sobral-Reyes, A. Moran-Horowich, M. Sundberg, M. Lopez-Marfil, D. O. Lopez-Cantu, C. Probst, G. Ruiz-Esparza, K. Giannikou, E. Henske, D. Kwiatkowski, M. Sahin, D. R. Lemos

This paper develops a tissue-bioengineering strategy using TSC patient-derived kidney organoids to model rare kidney diseases in vivo and test therapeutic approaches.

bioRxiv · Oct 20, 2021Bioengineering

Identification of the lymphangioleiomyomatosis cell and its uterine origin

M. Guo, J. J. Yu, A. K. Perl, K. A. Wikenheiser-Brokamp, M. Riccetti, E. Y. Zhang, P. Sudha, M. Adam, A. Potter, E. J. Kopras, K. Giannikou, S. S. Potter, S. Sherman, S. R. Hammes, D. J. Kwiatkowski, , Y. Xu

This study identifies LAMCORE cells as the source of lymphangioleiomyomatosis, showing their uterine neural crest origin and identifying potential biomarkers and therapeutic targets.

bioRxiv · Oct 8, 2019 · PreprintCancer Biology